Paper49163
Short-course chemotherapy for pulmonary tuberculosis.
Fox W and 1 other. Am Rev Respir Dis, 1975. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Short-course chemotherapy for pulmonary tuberculosis. Papers, record 49163. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/49163
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Tuberculosis, Pulmonary | Major topic |
| Drug Resistance, Microbial | |
| Drug Therapy, Combination | |
| Humans | |
| Isoniazid | |
| Pyrazinamide | |
| Rifampin | |
| Streptomycin | |
| Thioacetazone | |
| Time Factors |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39993187 | Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/39993187 | PubMed |
| 32918195 | Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB. | Curr HIV/AIDS Rep | 2020 | https://conductscience.org/library/papers/32918195 | PubMed |
| 32132245 | The Bewildering Antitubercular Action of Pyrazinamide. | Microbiol Mol Biol Rev | 2020 | https://conductscience.org/library/papers/32132245 | PubMed |
| 28292983 | Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application. | mBio | 2017 | https://conductscience.org/library/papers/28292983 | PubMed |
| 25676682 | Safety and tolerability profile of second-line anti-tuberculosis medications. | Drug Saf | 2015 | https://conductscience.org/library/papers/25676682 | PubMed |
| 21401509 | Lessons from seven decades of antituberculosis drug discovery. | Curr Top Med Chem | 2011 | https://conductscience.org/library/papers/21401509 | PubMed |
| 339995 | Rifampicin for lepromatous leprosy: nine years' experience. | Br Med J | 1978 | https://conductscience.org/library/papers/339995 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/49163
GET https://conductscience.org/api/papers/v1/49163/authors